- Home
- KIO vs SIGA Comparison
KIO vs SIGA Comparison
Compare KIO & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIO
- SIGA
- Stock Information
- Founded
- KIO 2011
- SIGA 1995
- Country
- KIO United States
- SIGA United States
- Employees
- KIO 2400
- SIGA N/A
- Industry
- KIO Investment Managers
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- KIO Finance
- SIGA Health Care
- Exchange
- KIO Nasdaq
- SIGA Nasdaq
- Market Cap
- KIO 514.6M
- SIGA 515.1M
- IPO Year
- KIO N/A
- SIGA 1997
- Fundamental
- Price
- KIO $12.73
- SIGA $6.46
- Analyst Decision
- KIO
- SIGA
- Analyst Count
- KIO 0
- SIGA 0
- Target Price
- KIO N/A
- SIGA N/A
- AVG Volume (30 Days)
- KIO 136.5K
- SIGA 328.2K
- Earning Date
- KIO 01-01-0001
- SIGA 08-05-2025
- Dividend Yield
- KIO 10.82%
- SIGA 9.22%
- EPS Growth
- KIO N/A
- SIGA N/A
- EPS
- KIO N/A
- SIGA 0.67
- Revenue
- KIO N/A
- SIGA $120,330,310.00
- Revenue This Year
- KIO N/A
- SIGA N/A
- Revenue Next Year
- KIO N/A
- SIGA $95.31
- P/E Ratio
- KIO N/A
- SIGA $9.70
- Revenue Growth
- KIO N/A
- SIGA N/A
- 52 Week Low
- KIO $10.52
- SIGA $4.95
- 52 Week High
- KIO $13.59
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- KIO 64.63
- SIGA 42.33
- Support Level
- KIO $12.54
- SIGA $6.97
- Resistance Level
- KIO $12.81
- SIGA $7.32
- Average True Range (ATR)
- KIO 0.09
- SIGA 0.21
- MACD
- KIO 0.00
- SIGA -0.07
- Stochastic Oscillator
- KIO 77.78
- SIGA 7.53
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.